Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Globestar Therapeutics Corp (GSTC)

Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,047
  • Shares Outstanding, K 1,162,921
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,950 K
  • 60-Month Beta 1.49
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade GSTC with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $0.00 on 03/11/24
  • Latest Earnings Date 05/29/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Sell
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.07
  • Prior Year -0.05
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0006 +50.00%
on 04/03/24
0.0025 -64.00%
on 03/26/24
-0.0016 (-64.00%)
since 03/25/24
3-Month
0.0006 +50.00%
on 04/03/24
0.0025 -64.00%
on 03/26/24
+0.0001 (+12.50%)
since 01/25/24
52-Week
0.0006 +50.00%
on 04/03/24
0.0082 -89.02%
on 06/14/23
-0.0046 (-83.64%)
since 04/25/23

Most Recent Stories

More News
CORRECTING and REPLACING GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking Contract

Agency selected because of performance history and a deep understanding of the company's healthcare, technology, and lifestyle spaces. RICHLAND, WA / ACCESSWIRE / March 1, 2022 / GlobeStar Therapeutics...

GSTC : 0.0009 (unch)
GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking Contract

Agency selected because of performance history and a deep understanding of the company's healthcare, technology, and lifestyle spaces. RICHLAND, WA / ACCESSWIRE / March 1, 2022 / GlobeStar Therapeutics...

GSTC : 0.0009 (unch)
GlobeStar Therapeutics Corporation Addresses the Potential Link Between Neurodegenerative Disease and Parkinson’s Disease

Company will work with its team of professionals to determine if our proprietary medical treatment will help Parkinson's patients as well. RICHLAND, WA / ACCESSWIRE / February 4, 2022 / GlobeStar Therapeutics...

GSTC : 0.0009 (unch)
GlobeStar Therapeutics Corporation Has Been Upgraded to the QB Tier on OTC Markets

Company will move from the Pink tier to QB tier effective immediately while retaining the same ticker symbol. RICHLAND, WA / ACCESSWIRE / October 11, 2021 / GlobeStar Therapeutics Corporation (OTCQB:GSTC)...

GSTC : 0.0009 (unch)
GlobeStar Therapeutics Corporation Additional Progress Toward A U.S.-Based Clinical Trial.

Company has made progress with a major medical center in the Northeast and identified a path forward for this pharmaceutical. RICHLAND, WA / ACCESSWIRE / October 4, 2021 / GlobeStar Therapeutics Corporation...

GSTC : 0.0009 (unch)
GlobeStar Therapeutics Corporation Additional Progress Toward A U.S.-Based Clinical Trial.

Company has made progress with a major medical center in the Northeast and identified a path forward for this pharmaceutical. RICHLAND, WA / ACCESSWIRE / October 4, 2021 / GlobeStar Therapeutics Corporation...

GSTC : 0.0009 (unch)
GlobeStar Therapeutics Corporation Files New 8K Statement Focused On Progress, Market Acceptance, And A Potential Game-Changing Drug For Multiple Sclerosis

Company has made significant progress and identified a path forward for this pharmaceutical. RICHLAND, WA / ACCESSWIRE / September 20, 2021 / GlobeStar Therapeutics Corporation (OTCBB: GSTC) has filed...

GSTC : 0.0009 (unch)
GlobeStar Therapeutics Corporation Unveils New Corporate Website and Branding Campaign

New website goes live in tandem with a major branding campaign to be found in USA Today. RICHLAND, WA / ACCESSWIRE / July 21, 2021 / GlobeStar Therapeutics Corporation (OTC PINK:GSTC) is launching its...

GSTC : 0.0009 (unch)
GlobeStar Therapeutics Corporation To Be Seen In The Washington Football Team Yearbook All Season

RICHLAND, WA / ACCESSWIRE / July 15, 2021 / GlobeStar Therapeutics Corporation has partnered with the Washington Football Team Yearbook producers for inclusion in their annual book. GlobeStar Therapeutics...

GSTC : 0.0009 (unch)
AngioSoma, Inc. Is Officially GlobeStar Therapeutics Corporation.

FINRA Approval for the AngioSoma name change is effective immediately. RICHLAND, WA / ACCESSWIRE / July 6, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) is now officially GlobeStar Therapeutics Corporation (OTC...

GSTC : 0.0009 (unch)
SOAN : 0.0683 (+16.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GlobeStar Therapeutics Corporation is focused on providing medical research, development and treatments for wellness and disease. GlobeStar Therapeutics Corporation, formerly known as AngioSoma Inc., is based in RICHLAND, WA.

See More

Key Turning Points

3rd Resistance Point 0.0009
2nd Resistance Point 0.0009
1st Resistance Point 0.0009
Last Price 0.0009
1st Support Level 0.0009
2nd Support Level 0.0009
3rd Support Level 0.0009

See More

52-Week High 0.0082
Fibonacci 61.8% 0.0053
Fibonacci 50% 0.0044
Fibonacci 38.2% 0.0035
Last Price 0.0009
52-Week Low 0.0006

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar